title: [Mediastinal lymphomas].
abstract: Lymphomas infiltrating the mediastinum are a challenge for the treating physician as well as for the pathological diagnostics. The clinical scenario is often an emergency situation, while the pathologist is usually confronted only with small biopsy samples. Classical Hodgkin's lymphoma is by far the most frequently occurring lymphoma in the mediastinum and predominantly the nodular sclerosis subtype. In small and very sclerotic specimens it can be difficult to morphologically detect Hodgkin and Reed-Sternberg cells and to identify the characteristic phenotype by immunohistochemistry. Primary mediastinal large B‑cell lymphomas should be distinguished from classical Hodgkin's lymphomas as the treatment is different. This is characterized by the detection of sheets of blast cells, which immunohistochemically show a strong B‑cell phenotype (positivity for CD20 and CD79a), while CD30 can also often be expressed. The intimate biological relationship between classical Hodgkin's lymphomas and mediastinal large B‑cell lymphomas is illustrated by the existence of B‑cell lymphomas with intermediate features (so-called mediastinal grey zone lymphomas). It is important to recognize and diagnose these lymphomas as they are associated with a slightly inferior prognosis. Extranodal thymic marginal zone lymphomas of the mucosa-associated lymphoid tissue (MALT) type are a rare form of lymphoma encountered in the mediastinum, which can be associated with autoimmune diseases. T‑lymphoblastic lymphomas and leukemia, which occur predominantly in children and young adults, represent a rapidly growing precursor cell neoplasia and must be distinguished from thymomas in the differential diagnostics as well as from normal and hyperplastic thymus glands.
authors: Institut für Pathologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Deutschland.|Comprehensive Cancer Center Mainfranken (CCC MF), Würzburg, Deutschland.
authors: S
authors: S
authors: Rauthe
authors: Institut für Pathologie, Universität Würzburg, Josef-Schneider-Str. 2, 97080, Würzburg, Deutschland. Rosenwald@mail.uni-wuerzburg.de.|Comprehensive Cancer Center Mainfranken (CCC MF), Würzburg, Deutschland. Rosenwald@mail.uni-wuerzburg.de.
authors: A
authors: A
authors: Rosenwald
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D003937:Diagnosis, Differential; D006689:Hodgkin Disease / Q000145:classification / Q000175:diagnosis / Q000473:pathology; D006801:Humans; D008223:Lymphoma / Q000145:classification / Q000175:diagnosis* / Q000473:pathology*; D018442:Lymphoma, B-Cell, Marginal Zone / Q000145:classification / Q000175:diagnosis / Q000473:pathology; D008479:Mediastinal Neoplasms / Q000145:classification / Q000175:diagnosis* / Q000473:pathology*; D008482:Mediastinum / Q000473:pathology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000145:classification / Q000175:diagnosis / Q000473:pathology; D011379:Prognosis; D016539:Reed-Sternberg Cells / Q000473:pathology; D013945:Thymoma / Q000175:diagnosis / Q000473:pathology; D013953:Thymus Neoplasms / Q000175:diagnosis / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor
keywords: Grey zone lymphoma; Hodgkin’s lymphoma; Lymphoblastic lymphoma; MALT lymphoma; Mediastinal lymphoma